Search | Médecins Sans Frontières Access Campaign

89 results found
There are 2 active filters
Clear all filters
GlaxoSmithKline
UNAIDS

89 results found

Issue brief |

16 December 2021

Liposomal amphotericin B: Solving the access puzzle

Liposomal amphotericin B is a lifesaving treatment for several diseases. Collaborative work among stakeholders is essential to overcome persistent access barriers.

Tags COVID-19HIV/AIDSTropical & neglected diseases mucormycosiscryptococcal meningitisvisceral leishmaniasis (kala azar) liposomal amphotericin B UNAIDS

Sebastião da Silva, 43 years old, is unemployed and went out of his house to get food for his 3 kids and wife. He is a painter and is having a hard time getting a job.If I get the virus, I wouldn’t know what to do.”

Press release |

26 July 2021

Opposing countries must stop filibustering negotiations on ‘TRIPS Waiver’ at WTO

Ahead of the WTO General Council meeting, MSF urged the EU, Norway, the UK, and Switzerland to stop stalling the landmark proposal to waive IP on lifesaving COVID-19 medical tools.

Tags COVID-19 coronavirus UNAIDSWorld Health OrganizationWTO covid medical tools access

Letter |

30 June 2021

Letter to European Commission to stop blocking IP waiver of COVID-19 medical tools

Open letter from CSOs to the European Commission to stop blocking the WTO TRIPS Waiver on intellectual property of COVID-19 medical tools

Tags COVID-19 coronavirus TRIPS European CommissionUNAIDSWTO covid medical tools access European Union

Report |

13 May 2021

Ending cryptococcal meningitis deaths by 2030: Strategic framework

This Strategic Framework sets out the case for a re-invigorated global drive to end cryptococcal meningitis deaths by 2030, as part of a broader drive to end all HIV-related deaths, and outlines what essential programmatic elements are ...

Tags HIV/AIDS cryptococcal meningitis UNAIDSWorld Health Organization

Tinelbaraka Walet Brahim being vaccinated at a homestead in the village of Lemetrewegh in the Hodh ech Chargui region of Mauritania

Press release |

04 March 2021

MSF welcomes GSK’s commitment to supply the ‘Humanitarian Mechanism’ with lifesaving rotavirus vaccine

Médecins Sans Frontières/Doctors Without Borders (MSF) welcomes pharmaceutical corporation GlaxoSmithKline’s (GSK) announcement today of an agreement to supply rotavirus vaccine to the ‘Humanitarian Mechanism’.

Tags Vaccines rotavirus UNICEFWorld Health OrganizationGlaxoSmithKlinePfizer

Bambari hospital, Central African Republic

Press release |

22 February 2021

MSF welcomes African Union’s motion supporting IP waiver proposal at WTO

MSF welcomes the endorsement by the AU that encourages all countries in Africa to support this landmark proposal at the WTO that would allow countries to choose not to apply or enforce certain types of IP on COVID-19 medical tools ...

Tags COVID-19 coronavirus DNDiUNAIDSWTO covid medical tools access

covid 19 yemen patientbeingmoved jacobburns 2020

Press release |

11 November 2020

MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public

Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic.

Tags COVID-19 coronavirus vaccines Oxford UniversityAstraZenecaGlaxoSmithKlineJohnson & JohnsonPfizerSanofiSerum Institute of India covid medical tools access

Staff checking on patients. These are usual rounds where doctors check on the progress of the patient accompanied with a counsellor to get insights into their interactions with the patient as well.

Press release |

28 October 2020

MSF response to Gavi’s intent to purchase Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility

As Gavi, the Vaccine Alliance, signs an intent to purchase 200 million doses of vaccine for the COVAX Facility from Sanofi-GlaxoSmithKline (GSK), Médecins Sans Frontières/Doctors Without Borders (MSF) demands transparency from these ...

Tags COVID-19 coronavirus vaccines GlaxoSmithKlineSanofi covid medical tools access

John * and Jean * hold each other’s arms in the CHK. Jean was diagnosed with HIV in 2010. He was hospitalized in June 2019 for the first time. A few weeks after his release, he had to return urgently for a new hospitalization.

Press release |

06 July 2020

MSF response to the release of UNAIDS 2020 Global AIDS Update Report

UNAIDS released today its 2020 Global AIDS Update Report. MSF joins UNAIDS in calling for countries to implement practices to help mitigate the impact of COVID-19 on HIV treatment services.

Tags HIV/AIDS coronavirusHIV/AIDS UNAIDS

Vanessa, 9, receives her HPV vaccination at school. Chiradzulu District, Malawi.

Photo story |

03 March 2020

Preventing cervical cancer in Malawi

In late January 2020, in conjunction with the Ministry of Health, MSF implemented an HPV vaccination campaign for 8,500 nine-year-old girls in the Chiradzulu district of Malawi.

Tags Vaccines Cervical cancer GlaxoSmithKlineMerck

The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece.

Press release |

29 January 2020

Global vaccines community must urgently support rollout of new more affordable pneumonia vaccine

Global vaccines community must do everything it can to help introduce the new, more affordable pneumonia vaccine in all countries, especially middle-income countries

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccine access to medicines Gavi, the Vaccine AllianceGlaxoSmithKlinePfizerSerum Institute of India

Gavi, the Vaccine Alliance, 20 year anniversary

Press release |

21 January 2020

As Gavi turns 20, MSF urges the vaccine alliance to protect more kids from pneumonia

As Gavi, the Vaccine Alliance, starts to commemorate its 20th year and launches a new fundraising appeal, MSF stresses that more must be done to make sure the 55 million children who do not have access to the pneumonia vaccine are ...

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccine Gavi, the Vaccine AllianceGlaxoSmithKlinePfizer

Facts about pneumonia vaccine - January 2020

Infographic

More affordable pneumonia vaccine can protect more kids

Tags Vaccines pneumococcal disease access to medicines GlaxoSmithKlinePfizer

Press release |

02 December 2019

US$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

Ahead of this week’s board meeting of Gavi, MSF calls on board members to immediately stop paying out funds from a remaining US$262 million subsidy to the pharmaceutical corporations Pfizer and GlaxoSmithKline (GSK) for the ...

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccine Gavi, the Vaccine AllianceGlaxoSmithKlinePfizer

Report |

29 November 2019

No time to lose: detect, treat and prevent AIDS

AIDS related mortality remains high - 770,000 deaths in 2018 - and has hardly declined in recent years. This report, compiled by MSF, presents data from the AHD dashboard initiated by the HIV Advanced Disease Consortium (HIV-ADC).

Tags HIV/AIDS HIV/AIDS UNAIDS

From Guidelines to Reality Accelerating Access to Prevention and Treatment of Paediatric HIV

Technical brief |

28 November 2019

From guidelines to reality: Accelerating access to prevention and treatment of paediatric HIV

This report examines the barriers to preventing new paediatric HIV infections and to providing timely and optimal treatment where we have failed to prevent transmission.

Tags HIV/AIDS HIV/AIDS UNAIDS Untangling the Web of Antiretroviral Price Reductions

MSF logistician, Athanasios Papadopoulos holding a sign advocating for broader use of the pneumonia vaccine at a lower price

Photograph by Anna Pantelia

Blog |

27 August 2019

The Inconvenient Truth About Pneumonia Vaccines

Almost a million young lives are taken every year by a single disease — pneumonia. This equates to a quarter of all deaths among children under 5.

Press release |

17 July 2019

Fight is not over as AIDS deaths remain high

More than 770,000 people died of HIV worldwide in 2018. These are disturbing figures in the UNAIDS Global Aids Update 2019 released in Eshowe, South Africa.

Tags HIV/AIDS HIV/AIDS UNAIDS

Infographic

Stop Big Pharma Profiteering

Tags Intellectual property and trade GlaxoSmithKlineJohnson & JohnsonNovartisPfizerRocheSanofi European Union

Interview

Profile of a Campaign: From Public Pressure to Saving Lifes

In this interview, Kate Elder, the Access Campaign’s Vaccines Policy Advisor who worked on the “A Fair Shot” campaign, talks about what this public advocacy and action achieved, and the lessons learned.

Tags Vaccines pneumococcal disease pneumococcal conjugate vaccine GlaxoSmithKlinePfizer A Fair Shot

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Liposomal amphotericin B: Solving the access puzzle

Opposing countries must stop filibustering negotiations on ‘TRIPS Waiver’ at WTO

Letter to European Commission to stop blocking IP waiver of COVID-19 medical tools

Ending cryptococcal meningitis deaths by 2030: Strategic framework

MSF welcomes GSK’s commitment to supply the ‘Humanitarian Mechanism’ with lifesaving rotavirus vaccine

MSF welcomes African Union’s motion supporting IP waiver proposal at WTO

MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public

MSF response to Gavi’s intent to purchase Sanofi-GSK COVID-19 vaccine candidate for the COVAX Facility

MSF response to the release of UNAIDS 2020 Global AIDS Update Report

Preventing cervical cancer in Malawi

Global vaccines community must urgently support rollout of new more affordable pneumonia vaccine

As Gavi turns 20, MSF urges the vaccine alliance to protect more kids from pneumonia

More affordable pneumonia vaccine can protect more kids

US$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

No time to lose: detect, treat and prevent AIDS

From guidelines to reality: Accelerating access to prevention and treatment of paediatric HIV

The Inconvenient Truth About Pneumonia Vaccines

Fight is not over as AIDS deaths remain high

Stop Big Pharma Profiteering

Profile of a Campaign: From Public Pressure to Saving Lifes